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Summary: During the procedure of centrifugation cytapheresis donors occasionally experience adverse clincial
reactions. We evaluated the possibility of whether activation of granulocytes and their subsequent release
reactions, which may have been triggered by this extracorporeal circuit, were responsible for these adverse
effects. Six blood samples were obtained during various set intervals during plateletapheresis. Of these, four
samples were taken directly from each donor. The remaining two were drawn from the efferent lines, i.e.
those which return blood from the cytapheresis machine back to the donor. Reactive oxygen species produced
by granulocytes were monitored by chemiluminescence using microamounts of whole blood or isolated
granulocytes. Furthermore, secreted granulocyte products such as neutral proteinase elastase, present in
plasma in a complex with oti-proteinase inhibitor (complexed elastase), and lysosomal -glucuronidase were
examined. A complete blood cell count, as well as values of haemoglobin, haematocrit, lactate dehydrogenase,
protein, albumin and proteinase inhibitors such as oc2-macroglobulin and αϊ-proteinase inhibitor were also
determined. Complexed elastase increased from a preapheresis value of about 140 μg/l to about 180 μg/l at
the end of the cytapheresis. All other clinical chemical and cytological values were 8 to 12 percent lower than
preapheresis values, which can be attributed to inherent plasma volume expansion. Reduced chemiluminescence
was observed upon stimulation of phagocytes in the whole blood assay (about 700 counts/min χ ΙΟ3 χ 50000
cells vs. about 600 counts/min χ ΙΟ3 χ 50000 cells). This decrease was also seen with stimulated granulocytes
(about 5800 counts/min χ ΙΟ3 χ 50000 cells vs. about 4500 counts/min χ ΙΟ3 χ 50000 cells). Unstimulated
granulocytes, on the other hand, showed an increased native chemiluminescence. These data do not, however,
indicate a cytapheresis mediated activation of the oxidative metabolism of granulocytes. Concomitant discharge
of proteolytic enzymes remains, therefore, of no clinical importance.
Introduction t 1 * 1 · ^ · ιlysosomal neutral protemases upon chemical or me-
Adverse clinical effects of donors during centrifuga- chanical stimulation. Reactive oxygen species and
tion cytapheresis have been reported in 4 to 25 percent neutral proteinases have been implicated in the path-
of cases (1 — 3). They have been classified as mild in ogenesis of acute tissue injury, particularly in the lung
severity and have required no therapy. Clinical signs (4). The activation of granulocyte oxidative metabo-
point, for the most part, to citrate toxicity. A possible lism and neutral proteinase release have been detected
alternative explanation is based on the assumption during extracorporeal circuit procedures such as hae-
that the mechanical cytapheresis procedure itself me- modialysis and cardiopulmonary bypass (5 —10). The
di tes activation and release reactions of distinct cell mechanism involved may also underlie similar clinical
types. The most likely cell type responsible for such adverse reactions during centrifugation cytapheresis.
a mechanism is the neutrophilic granulocyte, which Conventional laboratory programmes (2) designed to
has significant pathogenic potency, being capable of monitor the safety of cytapheresis are not specific for
discharging large amounts of toxic oxygen species and granulocytic activation and/or secretory products.
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Investigations of complement activation (11) and
functional analysis of monocytes and lymphocytes
during cytapheresis have been reported (12, 13). Sim-
ilar studies with granulocytes, however, remain to be
performed. The present investigation thus explores
humoral and cellular parameters in donor blood as
well as efferent blood taken from the IBM 2997 cy-
tapheresis machine. A key feature of this particular
unit is a ceramic rotary seal. It has been hypothesized
that the levels of shear stress in the rotary seal and/
or contact with the ceramic surface of the seal may
cause damage to blood cells (14). The emphasis of
the investigation was placed on parameters indicative
of the activation of granulocytes and subsequent
product release, but general cell injury markers were
also included.
Parameters of the investigation included the produc-
tion of reactive oxygen species, which were monitored
by chemiluminescence within microamounts of whole
blood or isolated granulocytes. Amounts of granu-
locyte products, such as neutral proteinase elastase
and lysosomal -glucuronidase, were determined.
Proteinase inhibitors, such as a2-macroglobulin and
ajrproteinase inhibitor, were also evaluated. A differ-
ential blood cell count, as well as haemoglobin, hae-




Blood was collected from healthy donors fulfilling the usual
requirements for blood donation. Informed consent was ob-
tained. Cells were collected by continuous flow centrifugation
using a cell separator (Model 2997, International Business Ma-
chines, Princeton, NY, USA) with centrifuge speed set at 1500
min"1.
Plateletapheresis
Forty eight donors were investigated. Four litres of blood were
processed during approximately 1.5 hours. Acid-citrate-dex-
trose (ACD-A, Pfrimmer, FRG) was used in a 1 to 8 ratio with
whole blood for the first litre and thereafter in a 1 to 10 ratio.
Heparin (2500 I. U., Liquemin, Hoffmann La-Roche, Switzer-
land) was given prior to plateletapheresis. Whole blood entered
the channel while approximately 250 ml of primer saline con-
taining 1000 I.E.β heparin (Vetren 200, Promonta, Hamburg,
F. R. G.) was extracted from the unit. The separation was then
started and after 41 of blood had been processed, 250 ml of
saline with heparin were again extracted from the unit.
Blood collection times for isolation of granulocytes
and plasma separation
Five ml anticoagulated blood (9 vol blood 1 vol sodium citrate,
31.3 g/1), were withdrawn directly from each donor undergoing
cytapheresis at the following times: before (Pre), half-way
through (Half), at the end of (End), and 30 min after termi-
nation of cytapheresis (Post). A blood sample (5 ml) was also
drawn from the efferent line of the cytapheresis machine with-
out citrate supplementation. Evaluations were made at the half
way point (Half) and at the end of the procedure (End). Blood
samples (2 ml) were simultaneously collected in EDTA coated
tubes for cell counts.
Plasma
An aliquot of citrated blood was centrifuged and the plasma
stored at — 70 °C for clinical chemical analysis.
Isolation of granulocytes
Granulocytes were separated from the interface of a two-step
discontinuous Percoll® gradient (Pharmacia, Sweden) (15, 16).
Chemiluminescence of whole blood and isolated
granulocytes
Upon interaction with particulate stimuli or chemical stimula-
tion, phagocytes respond with a chain of biochemical and
cytophysiological events commonly known as the respiratory
burst. An increased oxygen consumption of the cells is largely
converted into excited oxygen species which react with certain
biological substrates to become electronically excited products,
which generate light upon relaxation. The relatively poor quan-
tum yield of this native chemiluminescence response can be
increased more than a thousand fold by using cyclic hydracides,
such as luminol, as the bystander substrate (17). The major
chemiluminescence response of granulocytes to the particulate
stimulatory agent, zymosan, is brought about by the interaction
of the complement receptor type 3 of granulocytes with the
plasma-derived zymosan-coated cleavage products of comple-
ment fraction three, iC3b and to a minor degree C3b. In the
absence of plasma this receptor also mediates a chemilumi-
nescence response from the interaction with the zymosan po-
lysaccharide component, glucan (18).
Chemiluminescence assays of whole blood phagocytes and iso-
lated granulocytes were performed in polystyrene chemilumi-
nescence vials at 37 °C using a Biolumat 9505 equipped with a
six channel device (Berthold, Wildbad, F. R. G.). The vials were
not stirred during the assay. Chemiluminescence reaction mix-
tures for isolated granulocytes and whole blood were consti-
tuted as follows (18).
isolated granulocytes
500 μΐ Minimal Essential Medium Dulbecco (MEM) with 10 μΐ
luminol (0.4 mmol/1 final concentration) as the chemilumino-
genic agent, together with either 20 μΐ autologous plasma (CL1)
or 20 μΐ MEM instead of plasma (CL2). Twenty μΐ granulocyte
suspension (0.5 χ ΙΟ5 cells) were added to both vials. After
5 min incubation, the reaction was started with 20 μΐ ηοη-
opsonized zymosan (3.5 g/1). Controls without stimulus were
run in parallel (Cl and C2).
Whole blood
500 μΐ MEM and 10 μΐ luminol (0.4 mmol/1) plus 40 μΐ whole
blood (CL1). After 5 min incubation, the reaction was started
with 20 μΐ non-opsonized zymosan (3.5 g/1). A control without
stimulus was also included (Cl).
Chemiluminescence was continuously recorded. The following
chemiluminescence parameters were calculated from the meas-
urements:
(i) peak maximum counts/min values for the stimulation re-
actions (CL1 and CL2) as well as for the controls (Cl and
C2), representing the oxygenation capacity and the native
chemiluminescence, respectively.
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(ii) peak time values measured as the time in minutes required
to reach the peak maximum, representing an index of re-
ceptor affinity and/or concentration.
Haematologica l values and plasma chemis t ry
Studies included a complete blood cell count (erythrocytes,
thrombocytes, leukocytes, neutrophils, monocytes, lympho-
cytes), and the determination of haemoglobin and haematocrit
by standard procedures. Plasma analysis included: lactate de-
hydrogenase using a standard UV test; oci-proteinase inhibitor
using benzoyl-Z),L-arginine-/?-nitroanilide (a chromogenic sub-
strate); a2-macroglobulin using carbobenzoxy-valylglycyl-argi-
nine-/?-nitroanilide (a chromogenic substrate) (Boehringer,
Mannheim, FRG) (19 — 21); granulocyte elastase as elastase-ar
proteinase inhibitor complex (complexed elastase) using a solid
phase, enzyme-linked immunoassay (Merck, Darmstadt, FRG)
(22); -glucuronidase using a fluorimetric substrate (23); protein
using a standard biuret procedure; and albumin using the brom-
ocresol green method (24).
Data analys is
Due both to intravenous infusion and extravascular fluid move-
ment into the intravascular space, samples obtained during
cytapheresis were somewhat diluted. Data presented in table 1
are not corrected for the dilution. This holds true for all values,
except those of chemiluminescence, which are related to a
constant cell number. A correction factor was calculated by
dividing the albumin concentration in the preapheresis sample
by the albumin concentration in the sample during and follow-
ing apheresis. Statistical significance was tested against the
donor preapheresis value with Student's paired t-test.
Results
Adverse clinical reactions were not observed during
the investigation. Aside from complexed elastase, all
cytological and plasma chemical values were lower
both during and after cytapheresis, as compared with
the corresponding preapheresis values. The observed
decreases, however, were slight, but for the most part
they were statistically significant (tab. 1). The values
remained within their normal ranges. During plate-
letapheresis the actual values were 8 to 12 percent
lower than those obtained before apheresis. These
decreases were ascribed to plasma volume expansion
by ACD solution. Noteworthy among the cytological
values were significant decreases in the lymphocyte
and monocyte counts, but not in the granulocyte
count; this was caused by cell loss into the collection
bags (25) as indicated by exceptionally low values in
machine efferent fluid.
Only the complexed elastase concentration increased.
Using values adjusted for dilution, an increase over
the preapheresis value of about 140 μg/l to about 180
μg/l was observed in the plasma of probands. Higher
values were found in machine efferent fluid than in
corresponding donor fluid.
Chemiluminescence peak maximum values decreased
in whole blood (about 700 counts/min χ 103
χ 50000 cells vs. about 600 counts/min χ ΙΟ3
χ 50000 cells) as well as in isolated granulocytes
(about 5800 counts/min χ ΙΟ3 χ 50000 cells vs.
about 4500 counts/min χ ΙΟ3 χ 50000 cells for CL1)
during and after apheresis. The respective peak time
values, however, increased slightly. The chemilumi-
nescence peak maximum values from unstimulated
granulocytes (Cl and C2), i. e. native chemiluminesc-
ence, increased.
Discussion
The question of what causes adverse clinical reactions
during centrifugation cytapheresis has been the sub-
ject of several previous investigations. These studies
investigated the possible role of complement activa-
tion (11), lymphocyte and monocyte function (12)
and immunological changes (13). The potential role
of granulocytes, however, was not taken into consid-
eration.
Several acute and chronic disorders are associated
with neutrophil-mediated injury. Upon interaction
with a variety of soluble and particulate stimuli, neu-
trophils can generate large amounts of intermediate
products of oxygen reduction (e. g. Superoxide anion,
hydrogen peroxide, hydroxyl radical) with a concom-
itant discharge of primary and secondary granule
contents (e.g. elastase, cathepsin) (4). Increasing evi-
dence suggests that either one or both of these events
are involved in the frequently observed adverse re-
actions to other models of extracorporeal blood cir-
cuits such as dialysis and cardiopulmonary bypass
(5 — 10). In analogy, we have attempted to character-
ize the functional state of granulocytes from donors
undergoing centrifugation cytapheresis.
Noteworthy among the clinical laboratory parameters
observed in this study was the increase in plasma
complexed elastase. For several reasons, elastase de-
termination in plasma is a sensitive parameter of the
functional state of the granulocytes:
(1) the immunological test employed is sensitive for
granulocyte-elastase only (22);
(2) in a given volume of whole blood (haematocrit
0.43, 3.3 χ 109 granulocytes per 1) the intracell-
ular content of elastase (10000 μg/109 granulo-
cytes (26)) is 500-times higher than that of plasma
(140 μg/l reference value);
(3) the intravascular disappearance rate of complexed
elastase is 2.5 h (9); the blood collection time
intervals of 0.75 h and 0.5 h should therefore have
been short enough to detect changes.
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The values from machine efferent fluid were higher
than those from the corresponding donor fluid, in-
dicating a more preferential in-vitro release. Although
the tendency is definitive, this increase is by no means
of clinical importance. In contrast, increases of com-
plexed elastase values during haemodialysis of more
than -times above normal have been observed, de-
pending on the type of dialysis membrane used (6 — 9).
Accordingly, granulocyte/plasma ratios of only about
10 for ß-glucuronidase and lactate dehydrogenase
(based on normal plasma values of 230 mU/1 and 100
U/l, respectively, and a granulocyte content of 360
mU/109 cells and 140U/109 cells, respectively, (26))
cannot mirror the minor release reaction of the gran-
ulocytes.
Because of its occurrence in all blood cells (5.8 U/109
platelets, 142 U/109 mononuclear cells, 140 U/109
granulocytes, 4.1 U/109 erythrocytes) (27)), with a re-
sulting blood cell/plasma ratio of about 360, lactate
dehydrogenase can serve as a general cell injury
marker.
oti-Proteinase inhibitor and a2-macroglobulin are the
two major plasma antiproteinases capable of inacti-
vating granulocyte elastase; cxi-proteinase inhibitor
additionally acts as acute-phase protein (28). Consid-
ering the results for complexed elastase, it is not
surprising that these antiproteinases did not increase.
The cytapheresis time may be too short for an acute-
phase reaction to occur. However, during haemodi-
alysis, slight increases in oti-proteinase inhibitor and
a2-macroglobulin have been observed, although infre-
quently (6, 7).
Since the number of phagocytes was standardized, the
observed decreases in the stimulation reactions in
whole blood chemiluminescence and isolated granu-
locyte chemiluminescence are independent of plasma
volume expansion. One could, however, argue that
the decrease in chemiluminescence is the result of an
increased citrate concentration during the apharesis
procedure. We have, however, recently shown that
increasing the citrated plasma volume fraction while
holding erythrocyte and neutrophil numbers constant
results in steadily increasing peak maximum values.
In addition, a shift to a higher volume fraction of
citrated plasma against a lower volume fraction of
erythrocytes has been shown to increase peak maxi-
mum counts (18). The decrease in opsonin-dependent
(CL1), as well as in opsonin-independent (CL2) peak
maximum values from isolated granulocytes does not
indicate a more preferential plasma- or cell-mediated
alteration.
An increased chemiluminescence from isolated cells
in the resting state (Cl and C2) was found. This
increase suggests that the cytapheresis procedure gen-
erates a plasma component capable of stimulating the
oxidative metabolism by itself and/or interacting with
specific receptors on cell membranes. This saturation
and/or deactivation may then result in diminished
chemiluminescence upon stimulation. In contrast to
filtration cytapheresis, complement activation is un-
likely to occur during centrifugation cytapheresis (11).
Complement acitvation is characteristically accom-
panied by increased chemiluminescence activity by
stimulated cells (5, 10) and clinical symptoms of pul-
monary sequestration of leukocytes (9). In conclusion,
our results for granulocyte-related cellular and hu-
moral parameters provide no significant evidence of
cytapheresis-mediated activation or release reactions
of clinical consequence.
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